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1. Introduction 
Epidemiological evidence is overwhelming that exposure of the skin to ultraviolet radiation 
(UVR) can increase one’s risk of developing malignant melanoma. However the situation is 
complex, as melanoma development is associated with “intermittent” sun exposure, whereas 
epidermal keratinocyte-based skin cancers like squamous cell carcinoma (SCC) are associated 
with chronic UVR exposure. Thus it is difficult to talk in terms of a classical UVR carcinogenic 
mechanism for melanoma in general. Melanoma risk seems intricately associated with 
pigmentation characteristics. Genome wide association studies identify variants in genes 
involved in pigmentation as risk factors, generally the strongest signal being for the 
melanocortin receptor 1 gene (MC1R). One reason postulated to explain the odd relationship 
between UVR exposure and tumorigenesis is that there may be a unique carcinogenic 
mechanisms at play involving UVA, that is a weak carcinogen for skin cancer in general. 
Evidence for UVA causality in melanoma comes from some epidemiological studies, and to 
some extent from work with animal models. On the other hand, one can argue that there may 
not be a unique carcinogenic mechanism for melanoma, and that there are several factors that 
may help explain the apparent difference from typical mechanism of UVR mutagenesis 
involving classical UVR mutations. Firstly, in terms of normal cellular function, melanocytes 
principal function is to produce melanin pigment while epidermal keratinocytes are 
programmed to proliferate and then die as they generate and maintain the epidermis, a barrier 
for internal tissues and organs. Secondly, there may be genetic differences between individuals 
developing particular subtypes of melanoma and/or form of sun exposure. Thus particularly 
relates to susceptibility to naevus development, a critical factor associated melanoma 
development on the trunk, a site presumably receiving mainly “intermittent” sun exposure.  
2. Epidemiology of melanoma 
Major risk factors for cutaneous melanoma are shown below - approximate relative risk 
(RR) and 95% confidence intervals (CI) are shown in brackets (Gandini et al., 2005a; Gandini 
et al., 2005b):  
1. One atypical naevus (RR 1.60, CI 1.4-1.8) 
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2. Five or more atypical naevus (RR 10.5, CI 5.1-21.5). 
3. Multiple banal melanocytic naevi - 100 vs <15  (RR-6.9, CI 4.6-10.3). 
4. Red versus dark hair (RR 3.6, CI 2.5-5.4). 
5. Sunburns in childhood (RR 2.2, CI 1.73-2.89 
6. Sunburns in adulthood (RR 1.9, CI 1.6-2.7) 
7. Chronic sun exposure (RR 1.0, CI 0.8-1.1) 
Apart from familial predisposition, the strongest risk factor for the development of cancer 
generally, the presence of naevi, especially dysplastic naevi, is the innate, or phenotypic 
factor that most increases the probability of developing a melanoma. Sunlight is the only 
environmental factor that has been consistently implicated as a cause of melanoma, leading 
to a melanoma incidence 10- to 20- fold higher among fair-skinned than dark-skinned 
peoples (Armstrong & Kricker, 1993). Among fair-skinned people, melanoma incidence 
increases with proximity to the equator and several studies have shown that fair-skinned 
migrants moving from high (e.g. UK) to low latitude countries (e.g. Australia, South Africa) 
have lower melanoma rates than native-born residents (Whiteman and Green, 1999; Khlat et 
al., 1992; McCredie et al., 1990; McMichael and Giles, 1988). Individuals with xeroderma 
pigmentosum (XP), a disorder in which sufferers have a gene mutation that diminishes their 
ability to repair UVR-induced DNA damage, have much higher risk of melanoma than the 
population average (Kraemer et al., 1994; Cleaver, 2006). Those with a past history of non-
melanoma skin cancer (caused by high exposures to solar UVR) have a 3-fold higher risk of 
melanoma than the general population (Green et al., 1993). 
3. Genetic basis of melanoma 
3.1 Genes involved in familial melanoma susceptibility 
Although many different genes can be somatically mutated in melanoma, as yet there are 
only two confirmed familial melanoma susceptibility loci, CDKN2A and CDK4. CDKN2A 
encodes INK4A and ARF, which regulate cell cycle progression via the INK4A/CDK4/pRB 
and ARF/MDM2/p53 pathways respectively, although undoubtedly there is significant 
cross talk between these two pathways, and with other pathways. The overwhelming 
majority of CDKN2A mutations in melanoma-prone kindreds affect only the INK4A 
transcript, or both transcripts, but ARF-specific mutations also predispose to melanoma (e.g. 
Randerson-Moor et al., 2001; Rizos et al., 2001). As INK4A mutations generally prevent 
CDK4 from being bound and inhibited by p16INK4A, the mechanism of tumorigenesis with 
INK4A or CDK4 mutations is presumed to be equivalent (via pRB deregulation). Families 
carrying CDKN2A mutations usually, although not always, exhibit a naevus-prone 
phenotype (Goldstein et al., 2000) indicating that relaxation of melanocyte proliferation 
control induced by INK4A (or ARF) loss may be important in naevogenesis. However a 
recent study comparing the influence of sun exposure on melanoma risk in CDKN2A 
mutations carriers in Australia and the United Kingdom (Cust et al., 2011) suggests that they 
have to have the same cumulative risk of melanoma irrespective of the ambient UV 
irradiance in the region in which they live.   
3.2 Genes associated with melanoma in genome wide association studies 
Genome wide association (GWA) studies have been used to discover genes that confer risk 
for skin cancer development (Table 1). Some genes are associated both melanoma and non-
melanoma skin cancer, especially basal cell carcinoma (BCC). Five genes associated with 
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melanoma, SLC45A2, TYRP1, TYR, MC1R, and ASIP, encode proteins that are involved in 
various ways in regulating pigmentation. Little is known about how most of these may 
effect melanoma genesis and we are left to assume that the risk alleles may encode variants 
in these genes that simply result in lower levels of protective pigmentation. Notably, in 
respect to MC1R and ASIP (agouti signaling protein, an MC1R antagonist), there may be 
other explanations, which will be discussed below. The genes that confer the strongest risk 
for the development of naevi, MTAP/CDKN2A and PLA2G6, are not involved in the 








Melanoma BCC SCC 
1p36 PAD15 -  - ++ - 
1q42 RHOU -  - ++ - 
5p13.3 SLC45A2 ++  ++ ++ ++ 
5p13.33 TERT -  ++ ++ - 
6q25 IRF4 ++ +? +? - - 
7q32 KLF14 -  - ++ - 
9p21 CDKN2A -  - ++ - 
9p21 MTAP  ++ ++   
9q23 TYRP1 ++  ++ - - 
11q13.2 TPCN2 ++  - -  
11q14 TYR ++  ++ ++ - 
12q13 KRT5 -  - ++ - 
12q21 KITG ++  - -  
14q23 SLC2A4 ++  - -  
15q11 OCA2 ++  - - - 
15q13.1 HERC2 ++  - -  
15q21 SLC24A5 +  - - - 
16q24.3 MC1R ++  ++ ++  
20q11 ASIP ++  ++ ++ - 
22q13 PLA2G6  ++ ++   
Table 1. Adapted from Gerstenblith et al. (2010). A double plus sign (++) indicates a 
significant association (P < 10-7) in GWAS. A single plus sign (+) indicates an association (P 
between 0.01 and 10-7). A minus sign (-) indicates a null association (P > 0.01). A blank cell 
indicates that the locus in the left column has not been not tested. BCC=basal cell carcinoma. 
SCC =squamous cell carcinoma. 
3.3 MC1R, melanoma risk and sun exposure  
MC1R, the receptor for melanocyte stimulating hormone, is the most thoroughly studied 
melanoma risk gene. It functions largely to control the switch between red/yellow 
pheomelanin and black/brown eumelanin, hence it is sometimes referred to as the “red 
haired” gene. This gene is highly polymorphic in human populations with >65 variants 
documented. Variants have been classed into two groups based on the strength of their 
association with red hair (Sturm et al., 2003). The R variants (i.e. Asp84Glu, Arg151Cys, 
Arg160Trp, and Asp294His) are most highly correlated with red hair (mean OR 63.3, range 
50.5-118.3) although the r variants are still associated to a lesser degree (mean OR 5.1, range 
www.intechopen.com
 
Research on Melanoma: A Glimpse into Current Directions and Future Trends 
 
200 
2.4-6.4). MC1R variants are not the sole determinant of hair colour, twin studies have 
observed discordant hair colour but identical MC1R haplotypes (Box et al., 1997). The 
molecular consequences of UVR upon melanocytes with variant melanocortin-1 receptors 
are variable. This has lead to debate over MC1R classification and which variants to include 
in assessing the impact of impaired MC1R function in melanoma (Hacker & Hayward, 
2008). Beaumont et al. (2007) used in vitro studies to examine the functional impact of nine 
common MC1R variants and found that the V60L, D84E, R151C, I155T, R160W and R163Q 
variants showed impairment in cAMP coupling. Normal receptor expression was found for 
R142H and D294H variants, but reduced functional responses were observed, indicating 
that altered G-protein coupling may be responsible for this loss of function. The V92M 
isoform shows similar activity to the wild-type receptor, and along with V60L, is not 
associated with melanoma (Raimondi et al., 2008). Interestingly, melanoma risk due to the 
carriage of MC1R variants is stronger in individuals with dark hair and eyes, who do not 
have freckles, and tan well (Kanetsky et al., 2010). Thus the risk due to MC1R variation is 
certainly not limited to red heads. 
The mechanism by which the carriage of MC1R variants increases melanoma risk is an area 
of intense investigation. The simplest explanation is simply the lower photo-protection 
afforded by red/yellow pheomelanin than brown/black eumelanin. Notably, MC1R 
variants are also associated with increased risk of non-melanoma skin cancer (table 1). In 
addition, pheomelanin is more likely than eumelanin to generate potentially damaging 
reactive oxygen species following UVR exposure (Hill, 1992; Takeuchi et al., 2004; Baldea et 
al., 2009). A popular explanation for the protective role of MC1R comes from cell culture 
experiments showing that melanocytes carrying melanoma-associated MC1R variants have 
less effective repair of both UVR-induced pyrimidine dimers and oxidative damage than 
wild-type cells and are more sensitive to UVR-induced cell death (Kadekaro et al., 2005; 
Bohm et al., 2005; Hauser et al., 2006; Song et al., 2009). Functional MC1R appears to be 
necessary to prevent UV-induced genomic instability within melanocytes.  
4. The epidemiological association between sunlight and melanoma is 
complex 
Despite the persuasive descriptive evidence linking sunlight with melanoma, several 
observations make clear that the association is complex and does not accord with a simple 
model in which the risk of melanoma increases directly with increasing levels of exposure to 
the sun. Melanoma occurs more commonly among indoor than outdoor workers (Beral & 
Robinson, 1981). Even in sunny countries most melanomas develop on sites that are 
habitually covered by clothing (such as the back), as opposed to sites more frequently 
exposed to the sun such as the face (Green et al., 1993). Many case-control studies of 
melanoma incidence report stronger associations with intermittent (short periods of intense 
sun exposure to untanned skin) rather than chronic patterns of sun exposure (Elwood & 
Jopson, 1997). Recreational sun exposure is a risk factor for melanoma on the trunk and 
limbs but not on the head and neck (Chang et al., 2009).  
Chronic sun exposure and a “classical” UVR carcinogenic mechanism involving UVB-
induced DNA damage is accepted to be responsible for the development of SCC. One reason 
frequently proposed for the lack of association of melanoma with chronic sun exposure is 
that there may be a different carcinogenic mechanism for melanoma, possibly involving 
UVA exposure. The potential role of UVA in the induction of melanoma has been reviewed 
elsewhere (e.g. Wang et al., 2001; Moan et al., 2008; Godar et al. 2009). Sunlight at different 
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latitudes contains vastly different rations of UVA/UVB, with a greater proportion of UVB 
nearer the equator, and less closer to the poles. Because the change in melanoma incidence 
with latitude is much smaller than that for SCC (which is dependent upon cumulative UVB 
exposure) it is hypothesized that UVA play a role at least in exacerbating the development of 
melanoma (Godar et al., 2009; Wang et al., 2010). Other ideas revolve around the notion that 
office workers are at higher relative risk possibly due excessive UVA that can penetrate glass 
(Godar et al., 2009). Further, recreational exposure, generally agreed to increase melanoma 
risk, can include solarium use. Depending on the lamp type used, artificial tanning devices 
(sunbeds or solariums) emit higher UVA/UVB ratios and possibly higher UVA doses than 
found in sunlight (Miller et al., 1998; Gerber et al., 2002). A meta-analysis of nineteen studies 
has shown that exposure to sunbeds at a young age is the most damaging, with a relative risk 
for “first exposure under the age of 35” of 1.75 (95% CI, 1.35, 2.26) (International Agency for 
Research on Cancer Working group on artificial UV light and skin cancer, 2007). A large 
prospective cohort study of 106,366 women in Sweden and Norway showed that solarium use 
at ages 30-39 linked to a relative risk of 1.49 (95% CI, 1.11-2.00)(Veierod et al., 2011). Thus 
epidemiological evidence suggests that sunbeds are health hazards in terms of melanoma risk 
and that UVA has a plausible role in the development of this neoplasm. Hence 
epidemiological data is somewhat supportive of the view that the full UVR spectrum may be 
carcinogenic in melanoma. It should be noted that at any point on the earth it is difficult to 
precisely predict the UVA/UVB ratio in sunlight as it can greatly vary with time of day, 
altitude, latitude and climate factors (De Fabo et al., 2004). 
5. Naevus and melanoma subtypes 
From the point of view of basic biology differences between melanoma and non-melanoma 
skin cancer in terms of their relationship with UVR exposure is not surprising. Melanocytes 
are long living cells, resistant to apoptosis, whose principal function is to produce melanin. 
In contrast, the primary function of keratinocytes is to provide a protective barrier, the 
epidermis, which is in a continual state of regeneration, supplied by proliferation of 
epidermal basal layer keratinocytes that initiates a programmed process of differentiation 
and apoptosis as needed. Melanocytes can undergo a form of proliferation, where they form 
senescent groups, or nests, which are termed naevi. Such lesions are negative for 
proliferation markers, but can progress to malignancy, albeit at an extremely low frequency 
(Grichnik, 2008). There are multiple subtypes of naevi. These include dermal (blue naevi), 
compound (common acquired, spitz and congenital naevi) and epidermal (e.g. reed naevi) 
lesions (Grichnik, 2008). These subtypes may be influenced differently by UVR exposure, 
and there may be differences in their propensities for transformation (e.g. which is probably 
much less for dermal naevi). Hence the subtype of naevus can be a confounding factor when 
studying environmental and genetic factors influencing naevo genesis. For instance the 
positive association between naevus count and IRF4 gene variation (Duffy et al., 2010) varies 
greatly for different subtypes (dermal versus compound naevi).   
Likewise there are several major melanoma subtypes, and then subtle forms within each 
group. Superficial spreading melanoma (SSM) is the most common form in Caucasians 
(around 70% of all melanomas). It follows a radial growth phase with atypical melanocytes, 
either as single cells or nests at all levels of the epidermis (Smoller, 2006), followed by an 
invasive vertical growth phase. Nodular melanoma (NM) are primary dermal lesions 
characterized by growth through the dermis, generally lack epidermal involvement, and a 
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very sharply circumscribed with virtual lack of radial spread (Smoller, 2006). Lentigo 
maligna melanoma (LMM) is the only subtype unequivocally associated with chronic sun 
exposure. Lesions display confluent spread of melanocytes along the epidermal basal layer 
and in the upper portion of the hair follicle and are invariably associated with solar elastosis 
in adjacent skin (Smoller, 2006). SMM and NM, but not LMM, sometimes have naeval 
remnants present on histopathology. Acral lentiginous and mucosal melanomas are 
epidermal lesions that occur on palmoplantar and mucosal surfaces respectively, and  are 
assumed not to be influenced by UVR exposure. Clearly, any discussion of the effects of 
chronic versus intermittent sun exposure has to consider melanoma subtype.  
6. The divergent pathway model of melanoma 
To assess the effects of chronic versus intermittent sun exposure melanomas have been 
stratified into chronic sun damage (CSD) or non-chronic sun damage (non-CSD) 
melanomas, either histologically by assessing solar elastosis, a measure of chronic exposure 
(e.g. Curtin et al., 2005), or by comparing melanomas developing on the head and neck (an 
anatomical region of high cumulative sun exposure), and the trunk (a region of intermittent 
exposure). While these two methods of classification may create some confounding 
differences, overall the use of either system supports the conclusion of a complex 
relationship between melanoma and sun exposure that has lead to the proposal of a 
“divergent pathway” model (Whiteman et al., 2003). According to this model (Figure 1) the 
pathways diverge after an initial insult that stabilizes the melanocyte. This may be early life 
exposure to UVR given that childhood sunburns are a risk factor for melanoma (Whiteman 
et al., 2001). What happens thereafter depends upon a combination of host characteristics 
and subsequent patterns and doses of UVR exposure. Melanomas that develop on the head 
and neck are associated with solar elastosis (a marker of CSD), low naevus count, and 
relatively late age of onset. In contrast, melanomas developing on the trunk via the 
intermittent UVR (non-CSD) pathway tend to have relatively earlier age of onset and are 
associated with higher naevus count.  
 
 
Fig. 1. Schematic depiction of the divergent pathways model for melanoma development. 
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Several studies have published findings concordant with the divergent pathway hypothesis 
(Carli and Palli, 2003; Chang et al., 2009; Bataille et al., 1998). Given the strong association 
between truncal (non-CSD) melanomas and naevus development, and the fact that most 
naevi carry BRAF mutations (Pollock et al., 2003), it is not surprising that the non-CSD 
melanomas also tend to carry BRAF mutations (reviewed in Platz et al., 2008). A greater 
tendency for melanocytes to proliferate in this branch of the model has been proposed 
(Whiteman et al., 2001). This may manifest as innate propensity for “proliferation” (a 
tendency to form nests, i.e. naevi), or proliferation in response to UVR exposure. To our 
knowledge inter-individual variation in the latter has only been reported once. Stierner et al. 
(1989) exposed buttock skin (seven UVB exposures with dose gradually increased to give 
slight erythema), and collected biopsies three weeks after last exposure. They found 
variation in the melanocyte proliferative response to UVR. Individuals that showed the 
biggest increase had the lowest pre-existing density. There was no association between 
melanocyte number increase, minimal erythemal dose, or skin type (the presence, or not, of 
naevi was not mentioned). Hence, although the sample size was small, this study does 
indicate different proliferative potential of melanocytes between individuals. We cannot 
know how these responses influence melanoma development except in prospective studies, 
but we can begin to look at genes and other phenotypic measures that may stratify the two 
pathways and allow better predication of risk. There are some suggestions that not only 
naevus risk may be important, but also the propensity of individuals with less naevi to be 
prone to developing solar elastosis (Thomas et al., 2010). Arguing against this, individuals 
with DNA repair defects (e.g. XP patients) frequently develop lentigo melanomas without 
solar elastosis (Spatz et al., 2001), indicating that repeated or unrepaired UVR-induced DNA 
damage in the skin may be more important than the presence of solar elastosis per se.  To 
sum up, the divergent pathway hypothesis provides some basis for explaining why 
melanoma as a whole is most associated with intermittent sun exposure.  
7. Stratification of CSD and non-CSD melanomas by innate phenotypic and 
genetic variation 
7.1 MC1R variants 
Landi et al. (2006) reported that individuals in Italian and U.S. cohorts that developed 
BRAF-mutant melanomas via the “naevus” (non-CSD) pathway tended to carry MC1R 
variants more frequently than those developing CSD melanomas. However studies 
undertaken in cohorts from Australia and North Carolina found no association between 
germline MC1R status and somatic BRAF mutations in melanomas (Thomas et al., 2007; 
Hacker et al., 2010a). More recently, the Italian sample population originally reported in 
Landi et al. (2006) has been expanded to include another 92 melanomas and they reported 
that germline MC1R variants were associated with melanomas carrying BRAF-mutations 
independent of solar elastosis measures (Fargnoli et al., 2008). Conflicting data has 
continued to appear, with results from a German sample of 173 melanoma patients showing 
the opposite effect, with individuals carrying MC1R variants less likely to acquire somatic 
BRAF mutations in tumours (Scherer et al., 2010). MC1R is considered the most important of 
the “moderate” risk genes for melanoma. However its relationship to CSD versus non-CSD 
associated melanoma is a matter of debate. It is possible that the discordant study findings 
reflect that fact that MC1R is extremely polymorphic within and between ethnic 
populations, and that the small sample sizes for each study means that chance association 
with the non-CSD melanoma pathway cannot be excluded.  
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7.2 Genes controlling the development of naevi 
Given that the “intermittent” exposure arm of the divergent pathway is associated with the 
presence of naevi, we should be able to obtain clues about how to differentiate the pathways 
based on genes that confer naevus risk. Naevi are benign proliferations of melanocytes, and 
the number of naevi individuals tend to develop is under strong genetic control (English & 
Armstrong, 1994; Harrison et al., 1994). Monozygotic, or identical twin pairs, share all genes 
and have extremely highly correlated naevus counts (twin1 vs twin2, r=0.94), whereas 
dizygotic twin pairs share on average only half of their genes, and their naevus counts are 
considerably less correlated (r=0.60) (Zhu et al., 1999). The great majority naevi carry the 
BRAFV600E which seems to be an early event in melanoma development but not sufficient to 
transform naevocytes (Pollock et al., 2003). Instead, the expression of the mutant form in 
melanocytes leads to growth arrest characteristic of senescence (Michaloglou et al., 2005). 
However the presence of BRAFV600E does not inform in terms of how naevi might develop. 
Here we must look to genetic studies that might provide some hints to the molecular 
mechanisms involved. GWAS have also identified variants associated with development of 
naevi at chromosomal regions 9p21 and 22q13 (Falchi et al., 2009; Zhu et al., 2007). The 
strongest signal on 9p21 was located in the MTAP gene, which encodes 
methylthioadenosine phosphorylase, an enzyme involved in nucleoside metabolism. On 
22q13 the SNP with the highest association lies within PLA2G6, a gene belonging to the 
phospholipase A2 superfamily. Notably, the 9p21 locus accounted for 3.0% of nevus count 
variance, whereas the 22q13 locus accounted for only 0.7%. Thus the MTAP/CDKN2A locus 
is the strongest candidate region for naevus susceptibility. Clearly MTAP is an excellent 
candidate, but so is CDKN2A given its historical involvement in melanoma and the fact that 
individuals in families carrying CDKN2A mutations commonly have many naevi. It is 
thought that SNPs in the MTAP gene may confer long-range regulation of the CDKN2A 
locus. The various lines of evidence for long distance regulation of the CDKN2A locus are 
reviewed in Peters (2008). This would be an analogous situation to the OCA2 gene, whose 
influence on eye colour is not due to OCA2 coding variants, but to remote regulation by a 
SNP in the adjacent gene (Sturm et al., 2008). Another study on twins (Duffy et al., 2010) has 
revealed another association, this time with IRF4 (Interferon regulatory factor-4). Here the 
effect is somewhat weaker, and associated only with naevus development in an age-specific 
context (stronger effect in younger individuals). It will be very important to understand the 
mechanisms by which these genes confer naevus susceptibility given that the potential to 
develop naevi is the critical stratifying factor for the divergent pathways.  
The number of naevi an individual develops does not appear to just an innate trait, it may also 
be associated with levels of sun exposure, especially in children (reviewed in Gallagher et al., 
1995; Bauer et al., 2003). Recent studies examining the association of holidays overseas among 
young white English women found an increased in naevus count, particularly on anatomical 
sites intermittently exposed to sunlight, supporting the hypothesis that intermittent sun 
exposure is of relevance in the aetiology of naevi (Silva Idos, et al., 2009).  
7.3 UVR-induced proliferation of melanocytes 
Of possible relevance is how the branches of the divergent pathways differ in terms of the 
propensity of melanocytes in the skin to proliferate after UVR. Early studies in humans 
demonstrated that melanocyte density was correlated with sun exposure (Mitchell, 1963; 
Staricco & Pinkus, 1957; Stierner et al., 1989). Work by Quevedo and Colleagues (1965) 
reported that in mice melanocyte density increased up to 4-fold following repeated UVR 
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exposure, possibly due to increased mitotic activity of melanocytes (Rosdahl, 1978). More 
recent experiments have shown that melanocyte proliferation is greater following exposure 
to UVB than UVA, and that a single dose has a substantially greater effect than the same 
dose fractionated over several days (An et al., 2001; van Schanke et al., 2005). The generation 
of melanoma in mouse models using neonatal UVR is usually, although not always, 
accompanied by a strong proliferative response of melanocytes and their migration to the 
burnt area of the skin (Walker et al., 2009; Ferguson et al., 2010). Melanocyte proliferation 
would seem to be linked to the tanning response, which increases the amount of pigment in 
the skin, and is driven by UVB-induced damage to the skin. This is akin to “delayed tanning”, 
that can occur 1-5 d after exposure, and is primarily due to increased melanin production, 
although multiple exposures induce proliferation of melanocytes resulting in increased 
numbers in human skin (Yamaguchi et al., 2008). This is a long lasting protective 
pigmentation, unlike UVA-induced intermediate pigment darkening (IPD), which results from 
oxidation of pre-existing melanin, fades quickly, and is not protective against subsequent 
exposures. Interestingly, the induction of active melanocytes in mouse skin is also produced 
by chemical carcinogens, and the more carcinogenic the compound the greater the tanning 
response (Iwata et al., 1981). Liver carcinogens that are not metabolically activated in skin are 
ineffective. The compound most effective in inducing melanocyte proliferation was 7,12-
dimethylbenz[a]anthracene (DMBA), a very potent skin carcinogen. Thus the response of 
melanocytes is driven either by UVR or compounds that induce adducts within the DNA of 
skin cells.  
Melanocyte proliferation after UVR is thought to be driven by cytokines released by the 
microenvironment (Figure 2). UVR exposure modulates the production by keratinocytes 
(and probably other cells) of endothelins, Kit ligand (KITL), fibroblast growth factors (FGFs), 
and many others, which are all regulate melanocyte function (Hirobe, 2005; Lin & Fisher, 
2007; Imokawa, 2004). These include ┙-MSH (alpha melanocyte stimulating hormone), 
ACTH and a range of other growth factors. ┙-MSH and ACTH both bind to the MC1R on 
the surface of melanocytes, which activates the cyclic-AMP dependent kinase pathway, and 
the production of melanin pigments and possibly melanocyte proliferation. Most of these 
signaling molecules are known to enhance pigmentation, but little is known about how they 
might influence melanocyte proliferation in vivo. Mutations in mice that cause disruption 
keratinocyte function (resulting in epidermal thickening), for instance by germline activating 
keratin 4a or epidermal growth factor mutation (Fitch et al., 2003), or keratinocyte-specific 
ablation of 1-Integrin (López-Rovira et al., 2005), result in increased melanocyte numbers in 
the epidermis. This can also occur without epidermal hyperplasia by keratinocyte-specific 
overexpression of p53 (McGowan et al., 2008), Kit ligand (Kunisada et al., 1998), or, 
surprisingly, deletion of Fgf2 (Weiner et al., 2007). Treating human skin xenografted on to mice 
with exogenous FGF2, endothelin 3, and KITL resulted in the development of pigmented 
lesions, which only required UVB exposures repeatedly for one month for progression to 
melanoma (Berking et al., 2004). Hence signals from DNA damaged keratinocytes may play a 
role in inducing melanocytes to proliferate. To quote Lin and Fisher (2007), “could it be that 
keratinocytes are the primary UV responding population, and melanoma formation is largely a 
consequence of reactive secondary stimulation?” In fact the injection of highly active MSH 
analogues may be naevis promoting (Cardones et al., 2009; Langan et al., 2009). However the 
notion of UVR-induced melanocyte proliferation being melanomagenic is at odds with 
findings that stimulation of melanocytes with factor such as a-MSH (e.g. Bohm et al., 2005; 
Hauser et al., 2006; Abdel-Malek et al., 2009), Endothelin 1, (Kadekaro et al., 2005) and KITL 
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(Serre et al., 2011) improve DNA repair efficiency after UVR and are thus proposed to be 
protective for melanoma. Clearly we are only at the beginning of understanding how 
melanocyte UVR responses influence melanoma development. Whether genetic variation in 
humans that augment the proliferative response of an individual’s melanocytes to UVR could 
increase susceptibility to a particular pathway of melanoma development (as suggested by 
Whiteman et al., 2003, and Rivers, 2004) remains to be determined. 
 
 
Fig. 2. Pathways regulating melanocyte function. 
Keratinocytes expresses various growth factors that bind to melanocyte receptors that  
regulate critical intracellular pathways. Expression of these factors is increased after damage 
to the skin such as after UVR exposure. Germline mutations in p16INK4A and CDK4 (light 
blue) confer susceptibility to familial melanoma. KIT, NRAS and BRAF (white) are mutated 
somatically in melanomas. MC1R and ASIP variants (yellow) confer increased risk for 
melanoma development. In addition, macrophages that infiltrate the skin after UVR may 
stimulate melanocytes. Activation of the pathways depicted result in increased pigment 
production and distribution to adjacent keratinocytes, and increased survival, DNA repair, 
and proliferation of the melanocyte. 
7.4 Stratification of CSD and non-CSD by somatic mutations signatures 
Examination of melanomas of various subtypes by array comparative genome hybridization 
(CGH) has detected significant differences at specific genomic locations such that DNA copy 
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number differences could stratify melanomas into CSD, non-CSD, acral and mucosal 
melanomas (the latter two assumed not associated with sun exposure)(Curtin et al., 2005). 
Subsequently the same group detected activating mutations of KIT in 28% (n=18) of CSD 
melanomas versus 0% (n=18). This raised hopes that KIT mutation status may differentiate 
CSD and non-CSD melanomas, but a subsequent Australian publication (Handolias et al., 
2010) showed that the frequency of KIT receptor gene mutations in CSD melanomas is very 
low. Thus KIT mutation may not a good discriminator of CSD and non-CSD melanomas. In 
contrast, it has consistently been shown that mutation of KIT is much more common in acral 
and mucosal lesions (Curtin et al., 2005; Smalley et al., 2009). As described above we are left 
with fact that BRAF mutations are more common in melanomas arising in the non-CSD 
group, and a tendency for NRAS mutations to be more often present CSD melanomas. 
Notably the frequency of NRAS mutants in this group is relatively low, hence it would be 
only a signature for a small proportion of CSD melanomas. Nonetheless a recent meta-
analysis of all published studies showed that NRAS mutation is found in 24% of CSD 
melanomas and 17% of non-CSD melanomas and calculated that NRAS mutation is 
significantly associated with CSD melanoma (OR 1.9, 95% CI 1.11-3.20)(Lee et al., 2010). 
Despite the significant difference, NRAS mutation appears to be a weak discriminator of the 
CSD and non-CSD pathways. BRAF mutation is a better discriminator, having been found in 
30% of CSD melanomas and 49% of non-CSD melanoma. BRAF mutation is significantly 
associated with non-CSD melanoma (OR 2.4, 95% CI 1.35-3.10). Unlike SSM and NM, few 
LMs (10-20%) harbor BRAFV600E, (Hocker & Tsao, 2007). Hence there does not seem to be a 
strong mutations signature for the non-CSD pathway except for BRAF, which is mutated in 
over 80% of naevi. The stratification of CSD and non-CSD pathways in terms of BRAF 
mutation may have more to do with their differential association with naevus development 
than the forms of UVR exposure.  
8. Vitamin D and potential protective effects of chronic sun exposure on 
melanoma?  
Vitamin D has been shown to inhibit proliferation and induce differentiation in some 
melanoma cells, although melanoma cell lines have demonstrated resistance to vitamin D 
growth arrest (Danielsson et al., 1998,1999; Reichrath et al., 2007). A population-based study 
of 528 melanoma cases found that the presence of solar elastosis (dermal sun damage) was 
associated with a better prognosis for melanoma patients (Berwick et al., 2005). These 
findings have provoked speculation that as chronic sun damage induces a less aggressive 
form of melanoma (LMM), perhaps vitamin D levels might somehow slow melanoma 
growth and/or improve prognosis. To further determine if the anti-proliferative effect of 
vitamin D is modifying outcome for melanoma patients, Downing and colleagues, (2008) 
carried out a study to compare two populations with similar ethnic background but 
potentially different environmental influences. Patients diagnosed with invasive melanoma 
between 1993 and 2003 in Yorkshire (n= 4170) and New South Wales (NSW, n= 30,520) were 
identified from cancer registry databases and prognostic information (age, sex, 
socioeconomic background, tumour site and Breslow thickness) was examined. Five-year 
relative survival was 86.9% (95% CI, 85.2-88.5) in Yorkshire and 88.6% (95% CI, 88.1-89.1) in 
NSW. There was a suggestion of reduced risk for death in Australia, but differences in 
tumour thickness appeared to be the most important factor. The difference in survival may 
be due to the strong health promotion message for screening of skin cancer in Australia 
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resulting in increased detection of early thin lesions with better outcomes. A recent follow-
up study of 872 patients from the Leeds cohort (median follow-up, 4.7 years) has shown that 
higher 25-hydroxyvitamin D3 levels, at diagnosis, were associated with both thinner 
tumours and better survival from melanoma, independent of Breslow thickness (Newton-
Bishop et al., 2009). This data needs to be validated in additional sample sets and the level of 
vitamin D in the follow up period examined. Understanding the balance between optimal 
sun exposure to limit skin cancer risk while maintaining adequate vitamin D levels has been 
further complicated by work from Damian et al. (2010), which found that vitamin D had a 
presumably undesirable immunosuppressive effect when vitamin D analogues were applied 
topically to irradiated skin. On the other hand, Mason et al. (2010) reported that increased 
vitamin D levels reduced DNA damage in vitro following UVR and subsequently reduced 
UVR-induced immunosuppression in mouse and human skin. Currently data do not allow 
us to predict with any accuracy whether there may be a true causal influence of low Vitamin 
D levels on melanoma outcome. Although there is no solid evidence as such, we cannot 
discount that CSD melanomas may have an innately better prognosis because they are not 
associated with naevus susceptibility (certainly this would be the case for LMM which are 
well known to have better outcomes than SSM and NM).  
9. Animals as model systems for melanoma 
To mechanistically link sun exposure and melanoma is very difficult because individual sun 
exposure, especially based on recall, is difficult to assess, and the ratio of UVB/UVA varies 
greatly with geographical location, season, and time of day. This leads to great uncertainty 
in inferences about how different wavelengths influence melanoma development, hence 
sometimes model experimental systems can be useful, and animal models for carcinogenesis 
can provide complementary information when epidemiological studies have difficulty 
avoiding confounding factors. Grey horses and certain strains of pig are models for genetic 
susceptibility to melanoma, although there is no evidence for any effects of UVR exposure 
(Rosengren Pielberg et al., 2008; Seltenhammer et al., 2004). Opossom, guinea pigs and 
Angora goats have also been used as models for melanocytic lesion development (Chan et 
al., 2001; Menzies et al., 2004; Green et al., 1996). However except for goats, UVR exposure is 
not known to play any role in melanoma development in these animals. All of these species 
are very expensive to maintain, and generally limited in terms of the availability of reagents 
such as antibodies, and resources for genetic analyses. Various strains of fish including 
zebrafish (reviewed by Patton et al., 2010) and other fish species such as Xiphophorus 
(discussed in more detail below) are tractable models where UVR exposure can exacerbate 
the development of melanoma. 
9.1 Modeling chronic-induced melanoma in mice  
In contrast to the ability to induce SCC in wild type mice using chronic treatment regimens, 
a pre-existing genetically engineered mutation, and exposure of neonates, is necessary for 
inducing murine melanoma (Noonan et al., 2001). There are three reasons proposed to 
explain why mice develop melanoma after neonatal UVR, but not after chronic exposures to 
adult animals. First, neonatal mice have epidermal melanocytes that are likely to be 
damaged by UVR, whereas adult mice do not. Second, the heightened sensitivity of neonatal 
melanocytes to proliferation following UVR may be destabilizing (Walker et al., 2009), and 
third, the lack of inflammatory response to UVR in neonates may create a tolerant 
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environment for melanocyte transformation (Wolnicka-Glubisz et al., 2007; McGee et al., 
2011). It is thought that murine neonatal UVR may be somewhat analogous to childhood 
sunburn (Noonan et al., 2001). Despite it being a somewhat specialized system, there is 
much we can learn using the neonatal UVR about how UVR results in melanocyte 
transformation. For instance using the Mt-Hgf model (with overexpression hepatocyte 
growth factor throughout the skin) it has been shown that UVB, and not UVA, induces 
melanoma (de Fabo et al., 2004), and that use of sunscreen can attenuate its development 
(Klug et al., 2010).  
The skin of hairless mice contains some epidermal melanocytes, hence the animals represent 
a murine system amenable to chronic UVR exposures. Van Schanke et al. (2006) have carried 
out extensive UVR carcinogenesis studies on such animals carrying Ink4a/Arf deletion, with 
some cohorts also with co-deletion of the nucleotide excision repair gene Xpa. The mice 
developed naevi at a low rate spontaneously which was greatly increased by UVB treatment 
(how much depended upon the protocol and genotype). The naevi occasionally progressed 
to melanoma. Naevus development was dramatically increased by Xpa deletion, implicating 
UVB-induced pyrimidine dimer-type mutations in the pathogenesis of the lesions. 
Consistent with human melanoma, where intermittent exposures are most important, a 
single high dose erythemal exposure was much more effective at inducing naevi than the 
same dose delivered daily in a fractionated regimen (van Schanke et al., 2006).  
In terms of using adult mice for UVR studies, a major problem is that they do not have 
epidermal melanocytes (and murine melanomas that develop are mostly dermal). Mice 
overexpressing Kitl in their keratinocytes (K14-Kitl) have epidermal melanocytes throughout 
life (Kunisada et al., 1998). They do not develop melanoma after chronic UVR exposures 
(Yamazaki et al., 2005). Even when crossed onto a DNA repair defective background (Xpa-
null) no lesions were detected using a standard chronic UVB exposure protocol. But when the 
total UVB dose was increased over one half of the K14-Kitlg::Xpa-/- animals developed 
epidermal lesions reminiscent of lentigo and nodular melanomas (Yamazaki et al., 2005). Thus 
very high (almost physiological irrelevant) doses of UVB, plus a DNA repair defect, is need to 
induce transformation of the epidermal melanocytes in these mice. Interestingly, the animals 
developed very few SCCs, which both the high and low dose regimens do very effectively in 
wild type mice, hence it is thought that the extreme hyperpigmentation may be somewhat 
protective for both forms of skin cancer in this model. Nonetheless, murine epidermal 
melanocytes are apparently not totally resistant to transformation by UVR per se. It is possible 
that albino versions of the K14-Kitl model may have potential as a mouse model for chronic 
UVR-induced melanoma. Chronic UVR is somewhat effective in inducing melanomas in Tyr-
HrasG12V transgenic mice on an albino, but not pigmented strain background (Broome Powell, 
et al., 1999). However in Mt-Hgf transgenics chronic adult exposures do not exacerbate the 
development of melanoma (Noonan et al., 2001).  
10. Mechanisms of UVR carcinogenesis in melanoma 
10.1 Evidence of UVB causality in melanoma 
The ultraviolet spectrum that plays a physiological role in skin cancer development is 
arbitrarily divided into UVB (280-315 nm) and UVA 315-400 nm). Non-melanoma skin 
cancer (especially SCC) is undeniably associated with chronic UVR exposure, and tumours 
carry “classical” UVB signature mutations resulting from mis-repaired cyclobutane 
pyrimidine dimer (CPD) or pyrimidine (6-4) pyrimidone photoproducts (6-4 PPs) adducts. 
The action spectrum for SCC induction in mice, and the inferred action spectrum for SCC in 
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humans, peaks at 293 nm, firmly within the UVB range (de Gruijl et al., 1993). This overlaps 
with the action spectrum for CPD formation and sunburn. UVB, but not UVA, very 
effectively induces non-melanoma and melanoma skin cancer in mice (De Gruijl et al., 1993; 
De Fabo et al., 2004). Evidence of a critical role for UVB in melanoma induction comes from 
humans (van Steeg & Kramer, 1999) and mice (Yang et al., 2007) carrying nucleotide 
excision repair (NER) enzyme mutations (in XP genes) where melanoma incidence is 
dramatically increased after UVR exposure. XP patients have extreme sun sensitivity and 
burn very easily (van Steeg & Kramer, 1999). Melanomas from these individuals frequently 
carry TP53 and PTEN gene mutations that show classic C-T or CC-TT UVB signatures and 
lesions are similar in body site distribution associated with chronic UVR exposure (Spatz et 
al., 2001; Wang et al., 2009). Further, the majority of melanomas in these individuals appear 
to be of the lentigo type, but they do not exhibit the solar elastosis that is invariably present 
in the same melanoma subtypes developing in DNA repair-proficient individuals (Spatz et 
al., 2001). 
More information about the melanoma UVR mutation signature comes from the first 
melanoma genome sequence (Pleasance et al., 2010). Of 33,000 single point mutations 
detected, nearly 70% were C-T transitions. The only other nucleotide change above levels 
expected by chance were G-T transitions (9%) that can be a marker for UVA-induced damage 
(Agar et al., 2004). Notwithstanding the fact that only one melanoma, a secondary with 
undetected primary, was sequenced (Pleasance et al., 2010), and that some mutations could 
have been acquired by sun exposure during tumour development, these results suggest that 
CPD adducts may be critical driver of melanoma genesis. This is remarkably similar to the 
results of a recent review of all known CDKN2A and TP53 point mutations in melanoma 
(Hocker & Tsao, 2007) which found that the frequency of UVB-signature mutations (65 and 55 
% respectively) in these two genes in melanoma is similar to that found in SCC, a skin cancer 
with well-characterized UVB causality. Despite the presence of these UVR signature 
mutations, the overall mutation rate of these two genes in primary cutaneous melanomas is 
very low (7.9% and 11.8% respectively) (Hocker & Tsao, 2007), accounting for only about 10% 
of all melanomas. By comparison, BRAF or NRAS are mutated in more than 70% of all 
cutaneous melanomas (Hocker & Tsao, 2007). 
Although we usually concentrate on CPDs as the mutagenic adduct, UVB also induces 6-
4PPs, which are larger the CPDs, hence recognized and removed much more rapidly by 
nucleotide excision repair (NER). It has been hypothesized that 6-4PPs may be involved in 
melanoma induction, not via a mutagenic mechanism, rather via their deregulation of 
genome surveillance and transcription mechanisms leading to downstream changes that 
may deregulate the melanocyte (Mitchell et al., 2010). It is known that the two forms of 
UVB-induced photoproduct induce differential effects within cells (Lo et al., 2005). 6-4PP 
lesions are much more important in triggering cell death, whereas the response of the cell to 
CPD lesions mainly involves cell cycle arrest. An important role for 6-4PPs in melanoma is a 
speculative but interesting potential alternate aetiogy. Of note, 6-4PPs play no role in the 
generation of SCC in mice, CPD adducts are necessary and sufficient  (Jans et al., 2005).  
10.2 Evidence of UVA causality in melanoma 
In contrast to UVB, UVA is generally extremely inefficient at inducing CPDs, oxidative 
damage, erythema, and non-melanoma skin cancer in mice (De Gruijl et al., 1993; 
Besaratinia & Pfeifer, 2008; Runger & Kappes, 2008).  However UVA can induce 8-oxo-
guanine (8-oxoG) oxidative adducts that can results in the formation of G-T transversions 
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(Agar et al., 2004). Results of another study suggest that T-G transversion is a UVA 
“signature” (Drobetsky et al., 1995). UVA-specific lesions in the p53 gene have been detected 
in skin constructs and squamous tumours (Agar et al., 2004; Huang et al., 2009). In contrast, 
in vivo studies using “Big Blue” mice, and in vitro data, suggests that UVA-induced 
mutations are mainly of the pyrimidine dimer type (Mouret et al., 2006; Besaratinia & 
Pfeifer, 2008; Runger & Kappes, 2008). An interesting idea regarding the role of UVA in 
melanoma is that UVA and UVB generate a similar DNA mutation spectrum (although 
UVA is much less effective at inducing CPDs), but that UVA-induced cellular stress and 
repair response is not as great, thus lesions may not be as effectively removed (Runger & 
Kappes, 2008). Possibly this would only apply after relatively pure UVA exposures, for 
instance from solaria, or through glass. 
Notably, most of the studies mentioned above have used keratinocytes and fibroblasts, and 
not melanocytes to assess the mutagenicity of UVA. A recent study suggests that UVA is 
much more effective than UVB in inducing reactive oxygen species in melanocytes than in 
the other cell types (Wang et al., 2010). In addition, melanocytes are less efficient in 
removing CPDs and oxidative DNA damage. As discussed by Runger, (2011), these findings 
are at odds with some other studies, but nonetheless are indicative of potential differences 
between the responses of melanocytes and other skin cells to UVR. Runger, (2011) also raises 
the question of why if there is so much oxidative damage induced by UVA why are lesions 
typical for such stress vastly underrepresented in melanoma (e.g. Pleasance et al., 2010)? He 
suggests that this could relate to the low mutagenicity of 8-oxoG adducts.  
The ability of UVA to generate melanoma in Xiphophorus backcross fish is suggestive of a 
role for UVA in melanoma development (Setlow et al., 1989; Setlow, 1999). This has long 
been interpreted to infer UVA causality for melanoma, probably based on melanin 
photosensitization and subsequent oxidative damage to DNA. UVA is about 1000-fold less 
effective than UVB in inducing erythema and SCC, whereas in fish melanoma induction 
there is only about a 10-fold difference between the effects of UVB and UVA. Given the 
overwhelming preponderance of UVA in natural sunlight, if the fish action spectrum held 
up in humans, UVA would dominate melanoma causality. Xiphophorus are a complicated 
model. They carry photolyase, a light-inducible system that very rapidly and specifically 
repairs specific DNA adducts (e.g.. CPD-photolyase removes CDPs). Such repair systems 
are present in most of the plant and animal kingdom except for rodents and primates. Thus 
the fish experiments are carried out in the dark, and activation (by light) of the photolyase 
reduces melanoma incidence to background levels. Recently Timmins and colleagues used 
electron paramagnetic resonance assays to show that the action spectrum for melanoma and 
melanin radical production overlap (Wood et al., 2006), further evidence for melanin radical 
causation. However the notion that UVA is more effective than UVB in inducing melanoma 
in fish has been questioned by Mitchell et al., (2010), after similar experiments using 
apparently the same strain of fish. This conflicting result from the original study (Setlow et 
al., 1989) may be largely explained by the fact that latest study used more animals to make 
the results more statistically significant, and followed the fish for a longer time, allowing for 
later age of onset of some melanomas. Further, the fish also carry nucleotide excision repair 
activity, and melanoma development is exacerbated in fish with defective NER (Mitchell et 
al., 2007). The authors point out that UVA exposure is still potentially very important in the 
induction of melanoma in humans, but it may not be via a melanin radical-based mechanism.  
One would expect that if melanin sensitization were an important mechanism, we would 
not see the huge increase in melanoma risk for patients with XP, unless they also lacked a 
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defence against the melanin radicals.However there remains an anomaly that Africans with 
albinism (i.e. no melanin, or low levels), who practice poor sun protection, have been 
consistently shown to only very rarely develop melanoma (reviewed in Wood et al., 2006). In 
164 such patients in Tanzania actinic keratoses were found in 100%, and SCC in 34%, of albino 
individuals over 30 years old, but no melanomas were found (Lookingbill et al., 1995). In these 
cases childhood sunburns do not seem to drive subsequent melanoma development.  
The only other model used as evidence for UVA causality in melanoma is the South 
American opossum, Monodelphis Domestica, although the effect is weak (Mitchell et al., 2007). 
A study on focal pigmented hyperplasia developing in the opossum after UVA (Ley, 2001) 
showed that the action spectrum for the development of these lesions was much closer to 
the SCC action spectrum rather than the fish action spectrum. Nonetheless pure UVA does 
seem able to induce melanocyte proliferations in these animals, albeit not melanomas. 
Another interesting model is the guinea pig. These animals develop naevi after chronic UVB 
but not after chronic UVA exposures (Menzies et al., 2004). Neonatal UVB and not UVA 
induces melanoma in albino Mt-Hgf mice (De Fabo et al., 2004). In short, the fish is the only 
published model for UVA-induced melanoma and the conclusions have been questioned. 
However there is some evidence using pigmented Mt-Hgf mice that UVA can increase 
melanoma penetrance after neonatal exposure (Fisher et al., 2009, meeting report from the 
6th international melanoma congress), but it does not induce melanoma in albino Mt-Hgf 
mice. UVB effectively induces melanoma on both pigmented and non-pigmented 
backgrounds. Because the UVA effect is only seen in pigmented mice, the carcinogenic 
mechanism may involve increased oxidative stress induced by photosensitized melanin. 
Application of inhibitors of melanin synthesis before and after UVR exposure of appropriate 
animal models may provide an avenue to test the melanin radical hypothesis. It appears that 
the debate about the role of UVA in melanoma induction is not over.  
It must be pointed out that the murine and fish studies cannot model cumulative lifetime 
exposure to UVA in sunlight. We cannot rule out a role for UVA given that although the 
genotoxicity (i.e. frequency of dimers) is much higher in the UVB, UVA is far more 
abundant in sunlight (at least 20-fold). Not only are there debates about the role of UVA, 
there are even studies suggesting a protective role for UVA. Here, with UVB dose kept 
constant, increasing UVA dose protects against epidermal apoptosis (Ibuki et al., 2007) and 
SCC induction in mice (Forbes et al., 1978). Which wavelengths are critical for melanoma 
formation? In some ways this is irrelevant, and the real question is what type of adducts are 
needed? The balance of evidence to date suggests that the susceptibility of a melanocytes to 
UVR-induced transformation depends mostly upon the presence of classical CPD type 
adducts that if not properly removed result in C-T or CC-TT mutations. However this has 
not been formally proven.  
10.3 Role of UVR in generating BRAF and NRAS mutations 
The DNA base changes causing activating mutations in BRAF and NRAS do not represent 
classical UVB signatures, thus other mechanisms have been proposed for their causation. 
BRAFV600E is found in several internal malignancies, arguing against a specific role for UVR, 
and more suggestive of a role for generalized oxidative damage, or another mechanism 
(Dhomen et al., 2007). The BRAFV600E mutation is generally caused by a T>A transversion, 
and one theory regarding the possibly role of UVR in the generation of this change relates to 
error prone repair at the V600 mutation site in BRAF caused by adjacent pyrimidine dimers 
(Thomas et al., 2006). On the other hand, Besaratinia, & Pfeifer, (2008) show that there are 
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many types of lesions that can be induced by solar UVR, which although uncommon, could 
explain some of the mutations in detected in BRAF, particularly as there is selection pressure 
for the “required” the amino acid change. As discussed by Lund & Timmins, (2007) bulky 
adducts formed by reactive melanin species may be involved. None of these theories have 
been functionally tested. However in many melanomas the base change resulting in the 
NRAS codon 61 mutations is a G>T transversion (Hocker & Tsao, 2007). It has been 
experimentally confirmed in vitro using murine fibroblasts, that an 8-oxoG-mediated 
transcriptional mutagenesis mechanism greatly enhances the acquisition of such mutations 
(Saxowskya et al., 2008). Using a system that selected for clones carrying mutant HRASQ61 
mutations they showed that these were very rare in wild type murine fibroblasts but 
common in cells lacking the enzyme 8-oxoguanine DNA-glycosylase 1 (Ogg1), which 
repairs 8-oxoG lesions. The mutations were induced by G-T changes in the transcribed 
strand of the HRAS transcript. Thus while NRAS mutations may be induced in melanomas 
following UVB exposure, this mechanistic data best supports a role for oxidative adducts in 
their formation rather then CPDs. There is little mechanistic data to support the genesis of 
the BRAFV600E mutation from oxidative stress, only the observation that it is sometimes 
found in mucosal and acral melanomas, not associated with sun exposure, and in internal 
cancers (thyroid and colorectal) (Dhomen et al., 2007). 
It is difficult to glean much from murine melanoma models regarding the potential role of 
UVR in inducing BRAF or NRAS mutations. Braf mutations have not been detected in 
murine melanomas. One interesting finding comes from work with Ink4a/Arf-/-/Xpc+/- mice. 
These mice, essentially the only example of mice developing melanoma due to UVR 
exposure without carrying an engineered oncogenic mutation, resulted in development of 
melanomas that frequently carried KrasQ61 mutations. Similarly, melanomas induced by 
UVB in Ink4a/Arf-/-/Xpa+/- adult hairless mice occasionally carried an NrasQ61 mutation (van 
Schanke et al., 2006). The RasQ61 mutations in the NER-deficient mice were mainly G-T 
changes, again reflective of mis-repaired 8-oxoG adducts rather than mis-repaired CPDs.  
As suggested by Runger, (2011), oncogenes can only function as such due to very specific 
gain-of-function mutations that can only occur as certain amino acid changes, “thus the DNA 
base change may rather indicate a constraint on the amino acid change than the identity of the 
mutagen”. 
11. UVR, melanoma, and the immune system 
11.1 Immunosuppression 
There is undoubtedly an interplay between damaged melanocytes and immunocytes, 
whether just after UVR exposure or during tumour progression. It has long been known that 
the UVR exposure can suppress the immune system and create an environment tolerant to 
the growth of tumour cells that should be targeted for immunological destruction. Margaret 
Kripke and colleagues (Donawho et al., 1996) described how the growth of implanted 
tumours in mice is enhanced by local photoimmunosuppression. How much of a role it 
plays in melanoma development is unknown. Transplant patients taking 
immunosuppressive drugs are at a particularly heightened risk of skin cancer, particularly 
SCC, but it is a matter of debate whether they are at increased risk of melanoma. Out of nine 
studies recently reviewed (Bastiaannet et al., 2007), five reported between 2 and 4-fold 
increased risk, and four reported no increased risk. If immunosuppressed patients are at 
increased melanoma risk, it is low, and much less than the risk of developing SCC. Despite 
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this, individuals taking immunosuppressive drugs sometimes develop eruptive naevi, and 
this form of melanocyte proliferation is proposed to be due to the effects of 
immunosuppression rather than the drugs that induce it (Zattra et al., 2009).  
An important factor in the initiation of melanoma in mice by neonatal and not adult 
exposure is that neonates exhibit a defective inflammatory response to UVR compared to 
adults (Wolnicka-Glubisz et al., 2007; McGee et al., 2011). There may be ways to investigate 
the role that photoimmunosuppression plays in UVR-induced tumorigenesis. For example, 
(Jans et al. 2005) used mice carrying an inducible photolyase system that very rapidly 
removes CPDs from the skin after UVR exposure. Removal of CPDs from the whole skin 
significantly reduces both SCC development and immunosuppression. However, removal 
of CPDs specifically from the epidermal basal layer (using K14-Photolyase transgenics) 
similarly reduced tumorigenesis, but did not prevent photoimmunosuppression (Jans et al., 
2006). Thus immunosuppression seems to depend upon damage throughout the epidermis 
and dermis, whereas SCC is driven largely by UVR damage to basal layer keratinocytes, 
suggesting that immunosuppression may be important but not essential for the initiation of 
this skin cancer in mice  (at least in terms of UVR damage-driven SCCs). The relative 
contribution of direct DNA damage to melanocytes, and photoimmunosuppression, in 
melanoma needs to be clarified. 
11.2 UVR-induced inflammation 
One of the difficulties in studying UVR causality in melanoma is not only that multiple UVR 
response mechanisms such as DNA repair, proliferation and immune response play a role, 
but they are often not independent of each other. We can look at the normal response of 
melanocytes to UVR (Figure 2), in particular the multiple effects of cytokines that are 
released in the skin to activate melanocytes. Upon UVR-induced damage keratinocytes 
upregulate their expression of the pro-opiomelanocortin (Pomc) gene. Pomc encodes a pro-
peptide that is cleaved to generate ┙-MSH, ACTH and ┚-endorphin (Cui et al., 2007). 
Together, these peptides have pleiotropic effects on endocrine and neuroendocrine 
signaling, and the immune system (Brzoska et al., 2008), in addition to the melanotropic 
function of ┙MSH. Another protein upregulated in the epidermis after UVR exposure, KITL, 
can drive proliferation and migration of both pro-inflammatory mast cells as well as 
melanocytes (Kunisada et al., 1998). Pro-inflammatory cytokines like interleukin 12 (Schwarz 
et al., 2002) and interleukin-18 (Schwarz et al., 2006) can increase DNA repair capability of 
melanocytes after UVR exposure. In the case of interleukin-18, this may be via upregulation of 
KITL (Hue et al., 2005). Another secreted protein, previously known only for its role in 
immune responses to infectious agents, ┚-Defensin, is upregulated over 50-fold in human 
epidermis after UVR exposure (Enk et al., 2006) and is possibly involved in melanocye 
response to UVR as another ligand for the MC1R (Candille et al., 2007). Thus the release of 
cytokines within the skin not only activates the immune system, but also induces protective 
responses in the melanocye itself (e.g. increased pigmentation, proliferation, and DNA repair).  
The proliferative burst of melanocytes emanating from the upper portion of the hair follicle 
in neonatal mice presents an excellent opportunity to investigate how melanocytes are 
activated by UVR exposure. Zaidi et al. (2011) have cleverly utilized the power of the 
genetically modified mice to look into the mechanism of this melanocyte response. They 
used a genetically engineered mouse model inducibly expressing green fluorescent protein 
(GFP) in melanocytes. GFP was induced immediately after UVB exposure and melanocytes 
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were isolated via fluorescence activated cell sorting at various time-points after neonatal 
UVR. Gene expression array analysis on these cells detected a strong signature of interferon-
gamma (IFN)-induced genes that coincided with the appearance of melanocytes in the 
epidermis. It was subsequently shown that that the melanocyte response is largely driven by 
IFN released from infiltrating macrophages. Further experiments indicated that not only 
can macrophages influence melanocyte proliferation in the context of UVR exposure, but 
that they also contribute to the pro-tumorigenic inflammatory microenvironment of 
melanomas. This is possibly the first study to establish a direct link between the immune 
and melanocytic systems during the immediate skin response to UVR.  
12. Conclusion 
Because, measured on a population basis, melanoma induction by UVR appears to be via a 
very different mechanism (i.e. via intermittent exposure) than for keratinocyte-derived 
cancers (i.e. via chronic exposure), it has been postulated that there are different 
carcinogenic mechanisms at play (Setlow, 1999). Different mutagenic DNA adducts are 
proposed to be involved, including UVA-induced oxidative lesions, UVB-induced 
pyrimidine dimers and 6-4PPs. In studies of human populations individual sun exposure 
level, based on recall, can be difficult to assess, but also the ratio of UVB/UVA varies greatly 
with geographical location, season, and time of day. This leads to uncertainty in inferences 
about how much exposure and which wavelengths most influence melanoma development. 
However epidemiological work has lead to the proposal of the divergent pathway model for 
melanoma, where some melanomas develop as a result of intermittent exposure, others after 
chronic exposures (Whiteman et al., 2003). The major difference between the chronic and 
intermittent branches of the model is the presence of naevi, the great majority of which carry 
BRAF mutations, in the former. Naevi can develop spontaneously. Hence the presence of or 
propensity to develop naevi increases melanoma risk. Even limited sun exposure appears to 
increases this risk, whereas for individuals not prone to develop naevi a relatively high 
cumulative lifetime UVR damage may often be necessary. Nevus cells proliferate strongly, 
and move to a suprabasal (malignant-like) location if subjected to only a single UVB 
exposure in vivo (Carrera et al., 2008). Thus naevus cells, unlike normal melanocytes within 
the skin, are extremely sensitive to UVB-induced damage. It is not known if there is a 
mechanistic difference in UVR mutagenesis between the two CSD and non-CSD pathways. 
However, judging from the mutation spectrum in human melanoma, dominated by 
pyrimidine dimer type mutations, the most parsimonious conclusion may be that it is not 
necessary to invoke a different mutagenic mechanism per se to explain apparent differences 
in UVR causality between melanoma and non-melanoma skin cancer. In both cases 
pyrimidine dimer type DNA lesions are involved.  
If multiple carcinogenic mechanisms are at play, this can be tested in a number of ways. The 
stratification of melanomas into CSD and non-CSD has been critical in enhancing our 
understanding of divergent mechanisms of melanoma genesis, but since the two major 
forms of melanoma, SSM and NM can be associated with either forms of exposure, further 
stratification may be necessary (Of note, LMM clearly has a different aetiology from NM 
and SSM). This may be in the form of the discovery of better somatic mutation signatures, as 
well as further innate genetic differences between the two groups. The development of 
further tests to differentiate between the two groups could help in terms of targeting 
particularly susceptible groups within the population for health education campaigns and 
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more frequent screening. High throughput genome sequencing of large numbers of 
melanomas of various subtypes and association with CSD or non-CSD should clarify which 
type of DNA adducts are driving melanoma development, and in doing so might go some 
way towards clarifying the role of UVB versus UVA in the genesis of melanoma. Improved 
animals models should also be informative. 
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